Study of a plant extract with semaglutide for weight loss
Treatments studied
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests whether adding a plant-based supplement (called 20E) to the weight-loss medication semaglutide can improve weight loss and muscle health. You would take the supplement as capsules alongside your regular semaglutide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult with a body mass index (BMI) of 30 or more, or 27 or more with a weight-related health condition like high blood pressure or sleep apnea.
- You are about to start taking semaglutide (a weight-loss injection) for the first time as part of this study.
- You are willing to follow a diet with at least 1 gram of protein per kilogram of body weight each day and do at least 150 minutes of moderate exercise weekly.
- Your weight has been stable (within 11 pounds) for the last 3 months.
- You do not have diabetes, and you have not had gallbladder problems or surgery.
- You are not taking certain other medications or supplements (like herbal muscle builders or certain antidepressants) and agree to avoid them during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests a small implant placed under the skin that releases a weight management medicine (semaglutide) slowly over time. The goal is to see how safe it is and how your body handles it.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This study tests a nasal spray containing semaglutide (a GLP-1 receptor agonist) to see if it helps adults who are overweight or obese lose weight. It may be an option if you have a BMI between 27 and 35 and have not used other weight loss medications recently.
This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
Hear when a new Muscle Wasting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.